vs
CHART INDUSTRIES INC（GTLS）与ICU MEDICAL INC（ICUI）财务数据对比。点击上方公司名可切换其他公司
CHART INDUSTRIES INC的季度营收约是ICU MEDICAL INC的2.0倍（$1.1B vs $540.7M），CHART INDUSTRIES INC净利率更高（5.0% vs -2.9%，领先7.9%），CHART INDUSTRIES INC同比增速更快（-2.5% vs -14.1%），CHART INDUSTRIES INC自由现金流更多（$66.2M vs $36.0M），过去两年CHART INDUSTRIES INC的营收复合增速更高（6.6% vs -2.3%）
Oricon Inc.成立于1999年，是日本知名音乐产业集团的控股主体，主营日本本土及西洋音乐相关的行业资讯与数据统计服务。其前身为小池宗光于1967年11月创立的Original Confidence公司，凭借权威音乐排行榜广为人知，2002年4月正式承接原公司旗下的Oricon唱片排行榜业务。
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
GTLS vs ICUI — 直观对比
营收规模更大
GTLS
是对方的2.0倍
$540.7M
营收增速更快
GTLS
高出11.7%
-14.1%
净利率更高
GTLS
高出7.9%
-2.9%
自由现金流更多
GTLS
多$30.2M
$36.0M
两年增速更快
GTLS
近两年复合增速
-2.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $540.7M |
| 净利润 | $53.6M | $-15.7M |
| 毛利率 | 33.3% | 37.5% |
| 营业利润率 | 11.6% | 1.0% |
| 净利率 | 5.0% | -2.9% |
| 营收同比 | -2.5% | -14.1% |
| 净利润同比 | -32.7% | 34.0% |
| 每股收益（稀释后） | $1.06 | $-0.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GTLSICUI
| Q4 25 | $1.1B | $540.7M | ||
| Q3 25 | $1.1B | $537.0M | ||
| Q2 25 | $1.1B | $548.9M | ||
| Q1 25 | $1.0B | $604.7M | ||
| Q4 24 | $1.1B | $629.8M | ||
| Q3 24 | $1.1B | $589.1M | ||
| Q2 24 | $1.0B | $596.5M | ||
| Q1 24 | $950.7M | $566.7M |
净利润GTLSICUI
| Q4 25 | $53.6M | $-15.7M | ||
| Q3 25 | $-138.5M | $-3.4M | ||
| Q2 25 | $76.1M | $35.3M | ||
| Q1 25 | $49.5M | $-15.5M | ||
| Q4 24 | $79.6M | $-23.8M | ||
| Q3 24 | $69.0M | $-33.0M | ||
| Q2 24 | $58.6M | $-21.4M | ||
| Q1 24 | $11.3M | $-39.5M |
毛利率GTLSICUI
| Q4 25 | 33.3% | 37.5% | ||
| Q3 25 | 34.1% | 37.4% | ||
| Q2 25 | 33.6% | 37.9% | ||
| Q1 25 | 33.9% | 34.7% | ||
| Q4 24 | 33.6% | 36.1% | ||
| Q3 24 | 34.1% | 34.8% | ||
| Q2 24 | 33.8% | 34.8% | ||
| Q1 24 | 31.8% | 32.7% |
营业利润率GTLSICUI
| Q4 25 | 11.6% | 1.0% | ||
| Q3 25 | -8.0% | 2.6% | ||
| Q2 25 | 15.7% | 1.9% | ||
| Q1 25 | 15.2% | 2.1% | ||
| Q4 24 | 17.0% | 6.0% | ||
| Q3 24 | 16.8% | 1.4% | ||
| Q2 24 | 16.1% | 1.3% | ||
| Q1 24 | 11.9% | -1.9% |
净利率GTLSICUI
| Q4 25 | 5.0% | -2.9% | ||
| Q3 25 | -12.6% | -0.6% | ||
| Q2 25 | 7.0% | 6.4% | ||
| Q1 25 | 4.9% | -2.6% | ||
| Q4 24 | 7.2% | -3.8% | ||
| Q3 24 | 6.5% | -5.6% | ||
| Q2 24 | 5.6% | -3.6% | ||
| Q1 24 | 1.2% | -7.0% |
每股收益（稀释后）GTLSICUI
| Q4 25 | $1.06 | $-0.63 | ||
| Q3 25 | $-3.23 | $-0.14 | ||
| Q2 25 | $1.53 | $1.43 | ||
| Q1 25 | $0.94 | $-0.63 | ||
| Q4 24 | $1.57 | $-0.97 | ||
| Q3 24 | $1.33 | $-1.35 | ||
| Q2 24 | $1.10 | $-0.88 | ||
| Q1 24 | $0.10 | $-1.63 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $366.0M | — |
| 总债务越低越好 | $3.7B | — |
| 股东权益账面价值 | $3.2B | $2.1B |
| 总资产 | $9.8B | $4.1B |
| 负债/权益比越低杠杆越低 | 1.13× | — |
8季度趋势，按日历期对齐
现金及短期投资GTLSICUI
| Q4 25 | $366.0M | — | ||
| Q3 25 | $399.2M | — | ||
| Q2 25 | $342.3M | — | ||
| Q1 25 | $296.2M | — | ||
| Q4 24 | $308.6M | $308.6M | ||
| Q3 24 | $310.2M | $312.5M | ||
| Q2 24 | $247.4M | $302.6M | ||
| Q1 24 | $191.9M | $251.4M |
总债务GTLSICUI
| Q4 25 | $3.7B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $3.8B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益GTLSICUI
| Q4 25 | $3.2B | $2.1B | ||
| Q3 25 | $3.2B | $2.1B | ||
| Q2 25 | $3.4B | $2.1B | ||
| Q1 25 | $3.0B | $2.0B | ||
| Q4 24 | $2.8B | $2.0B | ||
| Q3 24 | $3.0B | $2.0B | ||
| Q2 24 | $2.7B | $2.0B | ||
| Q1 24 | $2.7B | $2.1B |
总资产GTLSICUI
| Q4 25 | $9.8B | $4.1B | ||
| Q3 25 | $9.8B | $4.1B | ||
| Q2 25 | $9.7B | $4.1B | ||
| Q1 25 | $9.3B | $4.2B | ||
| Q4 24 | $9.1B | $4.2B | ||
| Q3 24 | $9.5B | $4.3B | ||
| Q2 24 | $9.3B | $4.3B | ||
| Q1 24 | $9.2B | $4.3B |
负债/权益比GTLSICUI
| Q4 25 | 1.13× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.33× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $88.8M | $60.6M |
| 自由现金流经营现金流 - 资本支出 | $66.2M | $36.0M |
| 自由现金流率自由现金流/营收 | 6.1% | 6.6% |
| 资本支出强度资本支出/营收 | 2.1% | 4.6% |
| 现金转化率经营现金流/净利润 | 1.66× | — |
| 过去12个月自由现金流最近4个季度 | $202.8M | $91.8M |
8季度趋势，按日历期对齐
经营现金流GTLSICUI
| Q4 25 | $88.8M | $60.6M | ||
| Q3 25 | $118.0M | $56.7M | ||
| Q2 25 | $145.9M | $11.2M | ||
| Q1 25 | $-60.0M | $51.3M | ||
| Q4 24 | $281.4M | $40.2M | ||
| Q3 24 | $200.6M | $36.1M | ||
| Q2 24 | $116.1M | $82.0M | ||
| Q1 24 | $-95.1M | $45.8M |
自由现金流GTLSICUI
| Q4 25 | $66.2M | $36.0M | ||
| Q3 25 | $94.7M | $27.6M | ||
| Q2 25 | $122.0M | $-8.5M | ||
| Q1 25 | $-80.1M | $36.7M | ||
| Q4 24 | $260.9M | $16.1M | ||
| Q3 24 | $174.5M | $16.2M | ||
| Q2 24 | $88.0M | $62.5M | ||
| Q1 24 | $-141.2M | $29.9M |
自由现金流率GTLSICUI
| Q4 25 | 6.1% | 6.6% | ||
| Q3 25 | 8.6% | 5.1% | ||
| Q2 25 | 11.3% | -1.5% | ||
| Q1 25 | -8.0% | 6.1% | ||
| Q4 24 | 23.6% | 2.6% | ||
| Q3 24 | 16.4% | 2.7% | ||
| Q2 24 | 8.5% | 10.5% | ||
| Q1 24 | -14.9% | 5.3% |
资本支出强度GTLSICUI
| Q4 25 | 2.1% | 4.6% | ||
| Q3 25 | 2.1% | 5.4% | ||
| Q2 25 | 2.2% | 3.6% | ||
| Q1 25 | 2.0% | 2.4% | ||
| Q4 24 | 1.9% | 3.8% | ||
| Q3 24 | 2.5% | 3.4% | ||
| Q2 24 | 2.7% | 3.3% | ||
| Q1 24 | 4.8% | 2.8% |
现金转化率GTLSICUI
| Q4 25 | 1.66× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.92× | 0.32× | ||
| Q1 25 | -1.21× | — | ||
| Q4 24 | 3.54× | — | ||
| Q3 24 | 2.91× | — | ||
| Q2 24 | 1.98× | — | ||
| Q1 24 | -8.42× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GTLS
| Repair Service And Leasing Segment | $330.4M | 31% |
| Heat Transfer Systems Segment | $325.8M | 30% |
| Specialty Products Segment | $259.5M | 24% |
| Transferred Over Time | $94.4M | 9% |
| Transferred At Point In Time | $69.5M | 6% |
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
